imipenem, anhydrous has been researched along with Bacteroides Infections in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (8.82) | 18.7374 |
| 1990's | 9 (26.47) | 18.2507 |
| 2000's | 13 (38.24) | 29.6817 |
| 2010's | 5 (14.71) | 24.3611 |
| 2020's | 4 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Betriu, C; Culebras, E; Gómez, M; López, F; Picazo, JJ; Rodríguez-Avial, I | 1 |
| Hsueh, PR; Huang, YT; Liao, CH; Lin, HY; Liu, CY; Yen, LC | 1 |
| Angrup, A; Bala, K; Ray, P; Sood, A | 1 |
| AlAzmi, A; AlHashem, G; Jamal, W; Khodakhast, FB; Rotimi, VO; Sόki, J | 1 |
| Ikebuchi, K; Imai, K; Kawamura, T; Kodana, M; Maeda, T; Maesaki, S; Mitsutake, K; Murakami, T; Ogane, K; Onodera, A; Sakai, J; Takeuchi, S; Tarumoto, N | 1 |
| Ahmadinejad, Z; Emaneini, M; Fazeli, MS; Feizabadi, MM; Jasemi, S; Sadeghpour Heravi, F; Sechi, LA | 1 |
| Juhász, E; Kristóf, K; Latkóczy, K; Melegh, SZ; Miszti, C; Sárvári, KP; Sóki, J; Urbán, E | 1 |
| Jeverica, S; Nagy, E; Papst, L; Premru, MM; Sóki, J | 1 |
| Chong, Y; Jeong, SH; Kim, M; Kim, WH; Lee, K; Lee, Y; Seo, YH; Yim, J; Yong, D | 1 |
| Cascio, GL; Centonze, AR; Fontana, R; Macaccaro, L; Mazzariol, A; Sóki, J | 1 |
| Balkan, N; Ilki, A; Ozel, N; Söyletir, G; Toprak Ülger, N | 1 |
| García-Cano Lizcano, J; Gómez-Ruiz, CJ; Jimeno-Ayllón, C; Martínez-Fernández, R; Morillas-Ariño, J; Pérez-García, JI; Pérez-Sola, Á; Serrano-Sánchez, L | 1 |
| Arpin, C; Bezian, MC; Dubois, V; Gachie, JP; Gavinet, AM; Maire, JP; Menard, F; Quentin, C; Rogues, AM | 1 |
| Ackermann, G; Beer, J; Blatz, R; Rodloff, AC; Schaumann, R | 1 |
| Edwards, R; Fodor, E; Hecht, DW; Kerekes, I; Nagy, E; Rotimi, VO; Sóki, J; Urbán, E | 1 |
| Haldorsen, B; Onken, A; Sundsfjord, A; Toleman, MA; Walsh, TR | 1 |
| Cuadrado Pastor, JM; Jover Díaz, F; Martínez Tudela, S; Ortiz de la Tabla Duccase, V | 1 |
| Edwards, R; Fang, H; Hedberg, M; Nagy, E; Nord, CE; Sóki, J | 1 |
| Edwards, R; Gazis, A; Greenwood, D; Ispahani, P; Turner, P; Weston, V | 1 |
| Amyes, SG; Munn, JG; Thomson, CJ | 1 |
| Andremont, A; Carbon, C; Massias, L; Montravers, P | 1 |
| Brook, I; Ledney, GD | 1 |
| Bandoh, K; Kato, N; Ueno, K; Watanabe, K | 1 |
| Goto, S; Matsunaga, T; Nagashima, M; Ogawa, M; Shimohira, H; Yoshida, T | 1 |
| Aucher, P; Fauchère, JL; Grollier, G; Saunier, JP; Sebald, M | 1 |
| Fodor, E; Nagy, E; Sóki, J; Szöke, I; Urban, E | 1 |
| Edwards, R; Fodor, E; Nagy, E; Sóki, J; Urbán, E | 1 |
| Edwards, R; Fodor, E; Nagy, E; Sóki, J; Szoke, I; Urban, E | 1 |
| Edwards, R; Fodor, E; Lajos, Z; Nagy, E; Sóki, J; Urbán, E; Vrabely, T | 1 |
| Appelbaum, PC; Jacobs, MR; Spangler, SK | 1 |
| Cuchural, GJ; Hurlbut, S; Tally, FP | 1 |
| Brook, I | 1 |
| Brauner, E; Davey, P; Gorbach, S | 1 |
| Bourgault, AM; Delorme, L; Fijalkowski, C; Lamothe, F; Malouin, F | 1 |
34 other study(ies) available for imipenem, anhydrous and Bacteroides Infections
| Article | Year |
|---|---|
Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain.
Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; Bacteroides Infections; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Spain; Species Specificity; Time Factors | 2008 |
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; Blood; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Taiwan | 2008 |
Comparative evaluation of agar dilution and broth microdilution by commercial and in-house plates for Bacteroides fragilis group: An economical and expeditious approach for resource-limited settings.
Topics: Agar; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Clindamycin; Humans; Imipenem; Metronidazole; Microbial Sensitivity Tests | 2021 |
Prevalence and antimicrobial susceptibility of enterotoxigenic extra-intestinal Bacteroides fragilis among 13-year collection of isolates in Kuwait.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Toxins; Bacteroides fragilis; Bacteroides Infections; Cefoxitin; Clindamycin; Drug Resistance, Bacterial; Feces; Female; Humans; Imipenem; Kuwait; Male; Meropenem; Metronidazole; Microbial Sensitivity Tests; Piperacillin; Prevalence; Prospective Studies; Respiratory Tract Infections; Sepsis; Tigecycline; Wound Infection | 2020 |
Antimicrobial susceptibility and prevalence of resistance genes in Bacteroides fragilis isolated from blood culture bottles in two tertiary care hospitals in Japan.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; Blood Culture; DNA Transposable Elements; Doripenem; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Imipenem; Japan; Meropenem; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Piperacillin, Tazobactam Drug Combination; Prevalence; Sulbactam; Tertiary Care Centers | 2020 |
Antibiotic resistance pattern of Bacteroides fragilis isolated from clinical and colorectal specimens.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Bacteroides fragilis; Bacteroides Infections; Cefoxitin; Clindamycin; Cross-Sectional Studies; DNA, Bacterial; Drug Resistance, Bacterial; Gastrointestinal Tract; Genes, Bacterial; Humans; Imipenem; Inpatients; Metalloendopeptidases; Metronidazole; Microbial Sensitivity Tests; Penicillin G; Polymerase Chain Reaction; RNA, Ribosomal, 16S; Tetracycline | 2021 |
A multicentre survey of the antibiotic susceptibility of clinical Bacteroides species from Hungary.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Bacteroides; Bacteroides Infections; beta-Lactamases; Child; Child, Preschool; Female; Humans; Hungary; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Surveys and Questionnaires; Young Adult | 2018 |
High prevalence of division II (cfiA positive) isolates among blood stream Bacteroides fragilis in Slovenia as determined by MALDI-TOF MS.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Bacteriological Techniques; Bacteroides fragilis; Bacteroides Infections; beta-Lactam Resistance; beta-Lactamases; Child; Child, Preschool; Female; Humans; Imipenem; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Retrospective Studies; Slovenia; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Young Adult | 2019 |
Antimicrobial susceptibility of clinical isolates of Bacteroides fragilis group organisms recovered from 2009 to 2012 in a Korean hospital.
Topics: Anti-Infective Agents; Bacteroides fragilis; Bacteroides Infections; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Inhibitory Concentration 50; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Republic of Korea; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tazobactam; Tertiary Care Centers; Thienamycins | 2015 |
A new insertion sequence element containing a cfiA gene in the first imipenem-resistant Bacteroides fragilis strain isolated in Italy.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Bacterial; Female; Humans; Imipenem; Italy; Molecular Sequence Data; Sequence Analysis, DNA | 2009 |
[Can meropenem E-test be used to estimate the presence of carbapenem resistance gene cfiA among Bacteroides fragilis strains?].
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Feces; Humans; Imipenem; Meropenem; Metalloproteins; Microbial Sensitivity Tests; Thienamycins; Turkey | 2011 |
Liver abscess mimicking colon cancer.
Topics: Aged; Anti-Bacterial Agents; Bacteroides Infections; Cholecystectomy; Citrobacter freundii; Colonic Neoplasms; Colonoscopy; Combined Modality Therapy; Diagnostic Errors; Drainage; Enterobacteriaceae Infections; Fever; Humans; Imipenem; Liver Abscess; Male; Streptococcal Infections; Surgical Wound Infection; Tomography, X-Ray Computed; Ultrasonography, Interventional; Viridans Streptococci | 2011 |
Cross-infection due to imipenem-resistant Bacteroides fragilis associated with a totally implantable venous port.
Topics: Adult; Aged; Aged, 80 and over; Bacteremia; Bacterial Proteins; Bacterial Typing Techniques; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; Catheterization, Central Venous; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; Female; Genotype; Humans; Imipenem; Male; Middle Aged; Molecular Sequence Data; Neoplasms; Sequence Analysis, DNA; Thienamycins | 2002 |
Effect of moxifloxacin versus imipenem/cilastatin treatment on the mortality of mice infected intravenously with different strains of Bacteroides fragilis and Escherichia coli.
Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Bacteroides fragilis; Bacteroides Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; DNA, Bacterial; Drug Combinations; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Imipenem; Kidney; Liver; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Reverse Transcriptase Polymerase Chain Reaction | 2004 |
Molecular characterization of imipenem-resistant, cfiA-positive Bacteroides fragilis isolates from the USA, Hungary and Kuwait.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Bacteroides fragilis; Bacteroides Infections; Base Sequence; beta-Lactamases; DNA Transposable Elements; Drug Resistance, Bacterial; Humans; Hungary; Imipenem; Kuwait; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA; United States | 2004 |
Characterization of a carbapenemase-producing clinical isolate of Bacteroides fragilis in Scandinavia: genetic analysis of a unique insertion sequence.
Topics: Bacterial Proteins; Bacteroides fragilis; Bacteroides Infections; Base Sequence; beta-Lactam Resistance; beta-Lactamases; DNA Transposable Elements; Gene Expression Regulation, Bacterial; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Norway; Polymerase Chain Reaction; Promoter Regions, Genetic; Repetitive Sequences, Nucleic Acid; Sequence Analysis, DNA; Thienamycins | 2005 |
[Bacteroides fragilis meningitis in HIV patient].
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Cerebrospinal Fluid; Fatal Outcome; HIV Infections; Humans; Imipenem; Male; Meningitis, Bacterial; Middle Aged; Time Factors | 2006 |
Examination of cfiA-mediated carbapenem resistance in Bacteroides fragilis strains from a European antibiotic susceptibility survey.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteroides fragilis; Bacteroides Infections; Base Sequence; beta-Lactamases; Carbapenems; DNA Transposable Elements; Drug Resistance, Bacterial; Europe; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Population Surveillance; Thienamycins | 2006 |
Simultaneous resistance to metronidazole, co-amoxiclav, and imipenem in clinical isolate of Bacteroides fragilis.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacteremia; Bacteroides fragilis; Bacteroides Infections; Clavulanic Acids; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Empyema, Pleural; Female; Humans; Imipenem; Metronidazole | 1995 |
Effects of zinc concentration on the imipenemase activity of a metallo-beta-lactamase from a Bacteroides fragilis clinical isolate.
Topics: Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; Humans; Imipenem; Zinc | 1994 |
Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis.
Topics: Abscess; Amoxicillin; Animals; Anti-Bacterial Agents; Bacteremia; Bacteroides fragilis; Bacteroides Infections; Body Weight; Disease Models, Animal; Drug Synergism; Enterococcus faecalis; Escherichia coli; Escherichia coli Infections; Gentamicins; Gram-Positive Bacterial Infections; Imipenem; Male; Microbial Sensitivity Tests; Ornidazole; Pefloxacin; Peritoneum; Peritonitis; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms | 1994 |
The treatment of irradiated mice with polymicrobial infection caused by Bacteroides fragilis and Escherichia coli.
Topics: Abscess; Animals; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Feces; Female; Imipenem; Immunocompromised Host; Liver; Metronidazole; Mice; Microbial Sensitivity Tests; Ofloxacin; Whole-Body Irradiation | 1994 |
Susceptibility patterns and resistance to imipenem in the Bacteroides fragilis group species in Japan: a 4-year study.
Topics: Bacteroides; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; Drug Resistance, Microbial; Humans; Imipenem; In Vitro Techniques; Japan; Microbial Sensitivity Tests | 1993 |
[In vitro and in vivo activities of sulopenem compared with those of imipenem and cephalosporins].
Topics: Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; beta-Lactam Resistance; Cefotaxime; Ceftizoxime; Cephalosporins; Escherichia coli Infections; Gram-Negative Bacteria; Gram-Positive Bacteria; Guinea Pigs; Imipenem; Klebsiella Infections; Lactams; Lung Diseases; Mice; Mice, Inbred ICR; Thienamycins | 1996 |
Meningitis due to enterotoxigenic Bacteroides fragilis.
Topics: Antibodies, Bacterial; Antitrichomonal Agents; Bacteroides fragilis; Bacteroides Infections; Blotting, Western; Diagnosis, Differential; Enterotoxins; False Positive Reactions; Humans; Imipenem; Infant; Latex Fixation Tests; Male; Meningitis, Bacterial; Meningitis, Haemophilus; Metronidazole; Thienamycins | 1996 |
Prevalence of the carbapenemase gene (cfiA) among clinical and normal flora isolates of Bacteroides species in Hungary.
Topics: Bacterial Proteins; Bacteroides; Bacteroides Infections; beta-Lactamases; Blotting, Southern; Humans; Hungary; Imipenem; Meropenem; Metalloproteins; Microbial Sensitivity Tests; Polymerase Chain Reaction; Prevalence; Thienamycins | 2000 |
A clinical isolate of Bacteroides fragilis from Hungary with high-level resistance to imipenem.
Topics: Adult; Bacterial Proteins; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; Drug Resistance, Microbial; Humans; Hungary; Imipenem; Male; Microbial Sensitivity Tests; Polymerase Chain Reaction; Thienamycins | 2001 |
Occurrence of metronidazole and imipenem resistance among Bacteroides fragilis group clinical isolates in Hungary.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; DNA Transposable Elements; Drug Resistance, Microbial; Genes, Bacterial; Humans; Hungary; Imipenem; Metronidazole; Thienamycins | 2001 |
Isolation and characterization of an imipenem-resistant Bacteroides fragilis strain from a prostate abscess in a dog.
Topics: Abscess; Animals; Bacteroides fragilis; Bacteroides Infections; Dog Diseases; Dogs; Drug Resistance, Bacterial; Imipenem; Male; Prostatic Diseases; Ultrasonography | 2002 |
Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. cen
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteroides; Bacteroides Infections; beta-Lactamase Inhibitors; beta-Lactamases; Cefoxitin; Clavulanic Acid; Clavulanic Acids; Fusobacterium; Fusobacterium Infections; Imipenem; Metronidazole; Microbial Sensitivity Tests; Ticarcillin; United States | 1990 |
Imipenem resistance in Bacteroides distasonis mediated by a novel beta-lactamase.
Topics: Bacterial Proteins; Bacteroides; Bacteroides Infections; beta-Lactamase Inhibitors; beta-Lactamases; Culture Media; Drug Resistance, Microbial; Drug Synergism; Enzyme Induction; Imipenem; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Molecular Weight; Permeability | 1990 |
In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice.
Topics: Abscess; Ampicillin; Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Cefamandole; Cefotetan; Cefoxitin; Ceftizoxime; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Imipenem; Male; Mice; Skin Diseases; Sulbactam | 1989 |
Comparative study of clindamycin, imipenem, oxacillin and vancomycin in the infected granuloma pouch model.
Topics: Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Clindamycin; Granuloma; Imipenem; Male; Microbial Sensitivity Tests; Oxacillin; Rats; Rats, Inbred Strains; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1989 |
Bacteroides fragilis resistant to both metronidazole and imipenem.
Topics: Adult; Bacteroides fragilis; Bacteroides Infections; Drug Resistance, Microbial; Humans; Imipenem; Male; Metronidazole; Thienamycins | 1986 |